Asan Medical Center
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
2008 · Ann‐Lii Cheng, Yoon‐Koo Kang, et al. · The Lancet Oncology
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
2014 · Chetan Bettegowda, Mark Sausen, et al. · Science Translational Medicine
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
2017 · Anthony B. El-Khoueiry, Bruno Sangro, et al. · The Lancet